Form 4: TransDigm Director Sells $6M in Stock After Option Exercise

TransDigm Group director Robert J. Small exercised stock options and subsequently sold 4,700 shares of common stock for over $6 million on December 10, 2025.

Summary

• Robert J. Small, a Director of TransDigm Group INC (TDG), reported transactions on December 10, 2025.
• Small exercised stock options to acquire 4,700 shares of common stock at an exercise price of $66.47 per share.
• Immediately following the option exercise, Small sold all 4,700 shares of common stock in multiple transactions.
• The sales occurred at weighted average prices ranging from $1,289.3197 to $1,291.0322 per share.
• Total proceeds from the sale of 4,700 shares amounted to approximately $6,062,820.81.
• After these transactions, Small's direct beneficial ownership stands at 5,625 shares.
• Small also holds indirect beneficial ownership of 366,141 shares via Stockbridge Fund, L.P., 68,139 shares via Stockbridge Partners LLC, and 60,246 shares via Family Trusts.
• The transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can be perceived negatively, the transaction was pre-planned under a 10b5-1 plan, mitigating concerns about market timing. It represents a routine liquidity event for the director.

Positives

• The exercise of stock options indicates that the director realized value from previously granted equity compensation.
• The transactions were conducted under a Rule 10b5-1(c) plan, suggesting a pre-planned sale strategy rather than a reaction to recent market events.

Negatives

• The sale of 4,700 shares by a director represents a reduction in direct insider ownership, which can sometimes be interpreted negatively by the market.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders may note the reduction in direct insider ownership, though the pre-planned nature of the sale under a 10b5-1 plan suggests it is not a reaction to new negative information.

Key Dates

Recommendation

A Form 4 filing detailing an insider's exercise of options and subsequent sale of shares, especially when conducted under a 10b5-1 plan, typically does not provide sufficient new information to warrant a change in investment recommendation. It reflects a pre-scheduled liquidity event for the director rather than a signal about the company's future performance. Investors should maintain their current position and look for broader financial and operational updates.

Keywords

TransDigm Group, TDG, Robert J. Small, Insider Trading, Form 4, Stock Option Exercise, Stock Sale, Director Transaction, Equity Compensation, 10b5-1 Plan